Syros Pharmaceuticals, Inc. - Common Stock, $0.001 par value per share (SYRS)

Historical Holders from Q3 2022 to Q2 2025

Symbol
SYRS on OTC
Type / Class
Equity / Common Stock, $0.001 par value per share
Shares outstanding
27,196,692
All holders as of 30 Jun 2025
Q2 2025
Total 13F shares, excl. options
0
Holdings value
$0
Number of holders
0
Number of sells
-4
Average sells %
-0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Syros Pharmaceuticals, Inc. - Common Stock, $0.001 par value per share (SYRS)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Avidity Partners Management LP 7.6% $61,441 2,048,020 Avidity Partners Management LP 31 Dec 2024
Samsara BioCapital, L.P. 2.6% $21,213 707,114 Samsara BioCapital, L.P. 18 Nov 2024
ADAGE CAPITAL PARTNERS GP, L.L.C. 1.98% $15,957 531,914 Adage Capital Management, L.P. 31 Dec 2024
Point72 Asset Management, L.P. 0% $14.88 496 Point72 Asset Management, L.P. 31 Dec 2024

Institutional Holders of Syros Pharmaceuticals, Inc. - Common Stock, $0.001 par value per share (SYRS)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q2 0 $0 -$12,375 0
2025 Q1 462,954 $12,375 -$1,107,011 $0.0281 4
2024 Q4 5,216,797 $1,195,833 -$29,973,996 $0.2298 42
2024 Q3 18,942,451 $40,725,621 -$19,620,718 $2.15 64
2024 Q2 20,382,905 $105,175,826 -$2,839,834 $5.16 70
2024 Q1 20,915,564 $111,896,376 +$14,554,529 $5.35 74
2023 Q4 17,756,706 $138,325,248 +$53,999,700 $7.79 57
2023 Q3 12,136,541 $47,926,746 +$6,035,294 $3.95 47
2023 Q2 10,623,066 $33,463,045 +$1,179,405 $3.15 52
2023 Q1 10,299,991 $27,503,267 -$1,433,959 $2.67 53
2022 Q4 10,562,398 $37,917,223 +$7,584,586 $3.59 51
2022 Q3 8,426,635 $54,262,353 +$54,259,120 $6.44 41